Cargando…

KR-39038, a Novel GRK5 Inhibitor, Attenuates Cardiac Hypertrophy and Improves Cardiac Function in Heart Failure

G protein-coupled receptor kinase 5 (GRK5) has been considered as a potential target for the treatment of heart failure as it has been reported to be an important regulator of pathological cardiac hypertrophy. To discover novel scaffolds that selectively inhibit GRK5, we have identified a novel smal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jeong Hyun, Seo, Ho Won, Ryu, Jae Yong, Lim, Chae Jo, Yi, Kyu Yang, Oh, Kwang-Seok, Lee, Byung Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Applied Pharmacology 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457178/ https://www.ncbi.nlm.nih.gov/pubmed/32856617 http://dx.doi.org/10.4062/biomolther.2020.129

Ejemplares similares

Paroxetine Attenuates Cardiac Hypertrophy Via Blocking GRK2 and ADRB1 Interaction in Hypertension
por: Sun, Xuejing, et al.
Publicado: (2020)

The Amino-Terminal Domain of GRK5 Inhibits Cardiac Hypertrophy through the Regulation of Calcium-Calmodulin Dependent Transcription Factors
por: Sorriento, Daniela, et al.
Publicado: (2018)

Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition
por: Maning, Jennifer, et al.
Publicado: (2020)

GRK5 is a regulator of fibroblast activation and cardiac fibrosis
por: Eguchi, Akito, et al.
Publicado: (2021)

Cardiac GRK2 and the Communicative Axis Between Heart and Fat
por: Hill, Bradford G.
Publicado: (2022)

A Cardiac Amino-Terminal GRK2 Peptide Inhibits Maladaptive Adipocyte Hypertrophy and Insulin Resistance During Diet-Induced Obesity
por: Manaserh, Iyad H., et al.
Publicado: (2022)

Gallic Acid Reduces Blood Pressure and Attenuates Oxidative Stress and Cardiac Hypertrophy in Spontaneously Hypertensive Rats
por: Jin, Li, et al.
Publicado: (2017)

Pharmacological inhibition of GRK2 improves cardiac metabolism and function in experimental heart failure
por: Ciccarelli, Michele, et al.
Publicado: (2020)

Identification of new target proteins of a Urotensin-II receptor antagonist using transcriptome-based drug repositioning approach
por: Lim, Gyutae, et al.
Publicado: (2021)

Role of Irisin in Myocardial Infarction, Heart Failure, and Cardiac Hypertrophy
por: Ho, Ming-Yun, et al.
Publicado: (2021)

Curcumin Attenuation of Lipopolysaccharide Induced Cardiac Hypertrophy in Rodents
por: Chowdhury, Rupak, et al.
Publicado: (2013)

Alamandine attenuates hypertension and cardiac hypertrophy in hypertensive rats
por: Liu, Chi, et al.
Publicado: (2018)

Hispidulin Attenuates Cardiac Hypertrophy by Improving Mitochondrial Dysfunction
por: Wang, Yan, et al.
Publicado: (2020)

Gentisic acid prevents the transition from pressure overload-induced cardiac hypertrophy to heart failure
por: Sun, Simei, et al.
Publicado: (2019)

Targeting cardiac β-adrenergic signaling via GRK2 inhibition for heart failure therapy
por: Cannavo, Alessandro, et al.
Publicado: (2013)

Cardiac Hypertrophy
por: DaCosta,
Publicado: (1891)

Epigenetics in Cardiac Hypertrophy and Heart Failure
por: Liu, Chia-Feng, et al.
Publicado: (2019)

Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy
por: Li, Qiaoling, et al.
Publicado: (2016)

Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
por: Xu, Si-Chi, et al.
Publicado: (2017)

Context-independent essential regulatory interactions for apoptosis and hypertrophy in the cardiac signaling network
por: Kang, Jun Hyuk, et al.
Publicado: (2017)

Gentisic acid attenuates pressure overload‐induced cardiac hypertrophy and fibrosis in mice through inhibition of the ERK1/2 pathway
por: Sun, Simei, et al.
Publicado: (2018)

Shape dynamics in neutron-rich Kr isotopes: Coulomb excitation of $^{92}Kr$, $^{94}Kr$ and $^{96}Kr$
por: Albers, M, et al.
Publicado: (2013)

A Novel Urotensin II Receptor Antagonist, KR-36996 Inhibits Smooth Muscle Proliferation through ERK/ROS Pathway
por: Kim, Tae-Ho, et al.
Publicado: (2017)

GRK5 is an essential co-repressor of the cardiac mineralocorticoid receptor and is selectively induced by finerenone
por: Pollard, Celina M, et al.
Publicado: (2022)

Draft Genome Sequences of Pseudoalteromonas tetraodonis CSB01KR and Pseudoalteromonas lipolytica CSB02KR, Isolated from the Gut of the Sea Cucumber Apostichopus japonicus
por: Jo, Jihoon, et al.
Publicado: (2017)

AZD2014, a dual mTOR inhibitor, attenuates cardiac hypertrophy in vitro and in vivo
por: Cha, Byung-Hyun, et al.
Publicado: (2021)

Carbamazepine alone and in combination with doxycycline attenuates isoproterenol-induced cardiac hypertrophy
por: Errami, Mounir, et al.
Publicado: (2010)

Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II
por: Peng, Kesong, et al.
Publicado: (2016)

Roselle attenuates cardiac hypertrophy after myocardial infarction in vivo and in vitro
por: Si, Lislivia-Yiang-Nee, et al.
Publicado: (2019)

Andrographolide contributes to the attenuation of cardiac hypertrophy by suppressing endoplasmic reticulum stress
por: Tian, Qingxin, et al.
Publicado: (2022)

Cardiac hypertrophy at autopsy
por: Basso, Cristina, et al.
Publicado: (2021)

Cardiac Hypertrophy and Dilatation
por: Davis, M. T.
Publicado: (1915)

Inhalation of diesel exhaust does not exacerbate cardiac hypertrophy or heart failure in two mouse models of cardiac hypertrophy
por: Liu, Yonggang, et al.
Publicado: (2013)

Glucose Metabolism in Cardiac Hypertrophy and Heart Failure
por: Tran, Diem H., et al.
Publicado: (2019)

Noncoding RNAs in Cardiac Hypertrophy and Heart Failure
por: Lu, Peilei, et al.
Publicado: (2022)

Lifetime measurement in $^{74}$Kr and $^{76}$Kr
por: Görgen, A, et al.
Publicado: (2005)

Correction: Maning et al. Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition. Int. J. Mol. Sci. 2020, 21, 2868
por: Maning, Jennifer, et al.
Publicado: (2021)

Proteasome inhibitors attenuated cholesterol-induced cardiac hypertrophy in H9c2 cells
por: Lee, Hyunjung, et al.
Publicado: (2016)

Cardiac‐specific ablation of glutaredoxin 3 leads to cardiac hypertrophy and heart failure
por: Donelson, Jimmonique, et al.
Publicado: (2019)

Histone deacetylase inhibitor, CG200745, attenuates cardiac hypertrophy and fibrosis in DOCA-induced hypertensive rats
por: Lee, Eunjo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0a1vkec0h2f7e6khmrmmlh6gj0